We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$99B
AUM Growth
+$5.31B
Cap. Flow
-$322M
Cap. Flow %
-0.32%
Top 10 Hldgs %
14.08%
Holding
2,651
New
81
Increased
1,135
Reduced
556
Closed
97

Sector Composition

Rank Sector Weight
1 Healthcare 14.05%
2 Technology 13.96%
3 Financials 13.95%
4 Industrials 9.13%
5 Energy 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQV icon
976
IQVIA
IQV
$37.6B
$5.36M 0.01%
+100,501
New +$5.07M
WLK icon
977
Westlake Corp
WLK
$10.3B
$5.36M 0.01%
63,927
+59,527
+1,353% +$4.46M
SIG icon
978
Signet Jewelers
SIG
$3.78B
$5.35M 0.01%
48,383
-1,800
-4% -$187K
RLJ icon
979
RLJ Lodging Trust
RLJ
$1.89B
$5.35M 0.01%
185,073
+13,900
+8% +$378K
COLB icon
980
Columbia Banking Systems
COLB
$8.99B
$5.33M 0.01%
202,745
-21,419
-10% -$557K
DST
981
DELISTED
DST Systems Inc.
DST
$5.32M 0.01%
115,366
-38,792
-25% -$1.78M
PDM
982
Piedmont Realty Trust
PDM
$1.21B
$5.31M 0.01%
280,237
+3,600
+1% +$66K
EQC
983
DELISTED
Equity Commonwealth
EQC
$5.26M 0.01%
199,719
+8,700
+5% +$229K
MX icon
984
Magnachip Semiconductor
MX
$134M
$5.24M 0.01%
371,569
-40,121
-10% -$540K
GEVA
985
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
$5.23M 0.01%
49,900
-4,809
-9% -$409K
NIHD
986
DELISTED
NII HOLDINGS INC CL B
NIHD
$5.18M 0.01%
9,413,636
-2,231,768
-19% -$1.7M
CIB icon
987
Grupo Cibest SA
CIB
$21.4B
$5.14M 0.01%
88,945
-15,300
-15% -$870K
CYH icon
988
Community Health Systems
CYH
$417M
$5.12M 0.01%
136,588
+1,210
+0.9% +$40.3K
ESL
989
DELISTED
Esterline Technologies
ESL
$5.08M 0.01%
44,177
+7,280
+20% +$804K
ELS icon
990
Equity Lifestyle Properties
ELS
$12.6B
$5.04M 0.01%
228,360
+6,400
+3% +$137K
ESNT icon
991
Essent Group
ESNT
$6.14B
$5.04M 0.01%
250,800
-28,000
-10% -$569K
CDNS icon
992
Cadence Design Systems
CDNS
$93.8B
$5.03M 0.01%
287,271
-491,239
-63% -$7.85M
IM
993
DELISTED
Ingram Micro
IM
$4.98M 0.01%
170,568
+1,200
+0.7% +$33.7K
ITC
994
DELISTED
ITC HOLDINGS CORP
ITC
$4.98M 0.01%
136,400
-5,300
-4% -$196K
SHLD
995
DELISTED
Sears Holding Corporation
SHLD
$4.95M 0.01%
132,998
-28,400
-18% -$1.05M
THOR
996
DELISTED
THORATEC CORPORATION
THOR
$4.94M 0.01%
141,809
+9,565
+7% +$319K
VYX icon
997
NCR Voyix
VYX
$1.22B
$4.94M 0.01%
229,599
+1,467
+0.6% +$29.6K
IPCM
998
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
$4.85M ﹤0.01%
109,604
-12,251
-10% -$534K
SIRO
999
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$4.78M ﹤0.01%
57,955
-695
-1% -$52.9K
MTN icon
1000
Vail Resorts
MTN
$5.33B
$4.76M ﹤0.01%
61,668
+3,244
+6% +$228K

Similar funds

UBS AM's Q2 2014 Portfolio in Review

As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.

  • UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
  • UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
  • UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
  • UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
  • UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
  • UBS AM opened 81 new positions and closed 97 in Q2 2014.
  • UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.

Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.